News

2019

company

year

domain

SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System

Denali Therapeutics 01.09.2019

Moderna Announces Recent Progress in Its Immuno-Oncology and Rare Disease Programs and Highlights Corporate Objectives

Moderna 01.08.2019

Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive Officer

01.08.2019

Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL747 for ALS

Denali Therapeutics 01.08.2019

Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases

Sigilon Therapeutics 01.07.2019

Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference

01.07.2019

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines

01.04.2019

Evelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology Indications

Evelo Biosciences 01.04.2019

Jazz Pharmaceuticals and Codiak BioSciences Announce Strategic Collaboration to Research, Develop and Commercialize Engineered Exosomes to Create Therapies for Hard-to-Treat Cancers

01.03.2019

Seres Therapeutics Announces Initiation of SER-287 Phase 2B ECO-RESET Clinical Study for Ulcerative Colitis

Seres Therapeutics 01.03.2019

Loading